Name | Title | Contact Details |
---|
JeNu Biosciences was founded by a leading Washington bio scientist and a medical technology entrepreneur. While working on an ultrasound device for topical drug delivery, they became curious about using ultrasound to improve cosmetic skin care product delivery. High energy ultrasound has been proven effective at pushing drugs through the skin, but in the process cells are damaged and high heat causes intense pain. But since cosmetics only need to be absorbed into the top layer of skin rather than through the skin like drugs they thought a low energy ultrasound device might work. After many attempts they proved that low energy ultrasound wouldn`t help on its own. At the same moment, they had the idea that lead to the JeNu System. Rather than using ultrasound energy to vibrate cells in the skin to open up pathways, what if they vibrated microspheres on the skin to open the pathways. This idea lead to patent application 20120271222 and JeNu Biosciences. Launched in 2009, JeNu spent close to $10MM and 5 years on research, development and engineering. JeNu Biosciences is now proud to present the JeNu System. It`s the first pain free, at home, quick way to increase absorption of your favorite skin care products. In just one minute per target area per day the JeNu system is clinically proven to increase absorption by up to 12 times, and improve the efficacy of skin care products by up to 40% in just 7 days.
SignalPET offers advanced artificial intelligence-supported veterinary radiology. See how SignalPET can make a difference for your practice.
Endo Optiks Inc is a Little Silver, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We offer a unique suite of solutions, with a unique perspective on clinical research development. We focus on bringing together best-in-class science, technology and service to drive superior clinical outcome results for our clients and for their patients. Increasing the Power of Clinical Research Data.
Medical Facilities holds controlling interest in five specialty surgical hospitals located in Arkansas, Indiana, Oklahoma, and South Dakota. Medical Facilities` hospitals focus on a limited number of high volume, non-emergency surgical, diagnostic and imaging procedures. The case mix at each hospital is a function of the clinical specialties of the physicians on the medical staff and the equipment and infrastructure at each facility. Orthopedic and neurosurgical procedures represent a large portion of the case volumes at the hospitals. Medical Facilities also holds interest in ambulatory surgery centers located in Arkansas, California, Michigan, Missouri, Nebraska, Ohio, Oregon and Pennsylvania. The centers perform a broad range of outpatient procedures, with patient stays of less than 24 hours.